These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 21422963)
1. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China. Wang CQ; Zhu QR Pediatr Infect Dis J; 2011 Jul; 30(7):593-6. PubMed ID: 21422963 [TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey. Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581 [TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China. Zhang Q; Han F; Nie Q; Ren H; Zhang B; Liu Q; He Q; Shao Z J Infect; 2011 Dec; 63(6):441-6. PubMed ID: 21864569 [TBL] [Abstract][Full Text] [Related]
4. The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection. Rendi-Wagner P; Tobias J; Moerman L; Goren S; Bassal R; Green M; Cohen D Vaccine; 2010 Apr; 28(19):3285-90. PubMed ID: 20226250 [TBL] [Abstract][Full Text] [Related]
5. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults. Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia. Jõgi P; Oona M; Toompere K; Leedo S; Epstein J; Lutsar I Vaccine; 2014 Sep; 32(41):5311-5. PubMed ID: 25093282 [TBL] [Abstract][Full Text] [Related]
7. Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: waning pertussis immunity in a highly immunized population and the need for adolescent booster doses. Lai FY; Thoon KC; Ang LW; Tey SH; Heng D; Cutter JL; Phoon MC; Chow VT Vaccine; 2012 May; 30(24):3566-71. PubMed ID: 22475863 [TBL] [Abstract][Full Text] [Related]
8. Estimated and reported incidence of pertussis in Estonian adults: A seroepidemiological study. Jõgi P; Oona M; Toompere K; Lutsar I Vaccine; 2015 Sep; 33(38):4756-61. PubMed ID: 26277068 [TBL] [Abstract][Full Text] [Related]
10. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection. Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126 [TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka. Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children. Syed MA; Ahmed W; Naeem A; Bokhari H J Coll Physicians Surg Pak; 2012 Oct; 22(10):677-8. PubMed ID: 23058160 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of pertussis antibodies among adolescents in Israel. Arav-Boger R; Ashkenazi S; Gdalevich M; Cohen D; Danon YL Isr Med Assoc J; 2000 Feb; 2(2):174-7. PubMed ID: 10804947 [TBL] [Abstract][Full Text] [Related]
14. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection. Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults. Cherry JD; Chang SJ; Klein D; Lee M; Barenkamp S; Bernstein D; Edelman R; Decker MD; Greenberg DP; Keitel W; Treanor J; Ward JI Clin Infect Dis; 2004 Dec; 39(11):1715-8. PubMed ID: 15578376 [TBL] [Abstract][Full Text] [Related]
16. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. de Melker HE; Versteegh FG; Schellekens JF; Teunis PF; Kretzschmar M J Infect; 2006 Aug; 53(2):106-13. PubMed ID: 16352342 [TBL] [Abstract][Full Text] [Related]
17. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. Zhang Q; Zheng H; Liu M; Han K; Shu J; Wu C; Xu N; He Q; Luo H BMC Infect Dis; 2012 Jun; 12():138. PubMed ID: 22892100 [TBL] [Abstract][Full Text] [Related]
18. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. Nagel J; de Graaf S; Schijf-Evers D Dev Biol Stand; 1985; 61():325-30. PubMed ID: 2872120 [TBL] [Abstract][Full Text] [Related]
19. Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study. Li X; Chen M; Zhang T; Li J; Zeng Y; Lu L Hum Vaccin Immunother; 2015; 11(10):2434-9. PubMed ID: 26177302 [TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Bordetella pertussis immunoglobulin G antibodies among children in Samsun, Turkey. Ozkal A; Sensoy G; Acuner C; Belet N; Güney AK Turk J Pediatr; 2012; 54(1):15-9. PubMed ID: 22397036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]